
New Service Breaks Down Brain Tumor Clinical Trial Barriers
Only 12% of brain tumor patients in the UK join clinical trials—the lowest rate of all cancers. A new initiative called ACT-BT is changing that by connecting patients with potentially life-saving research opportunities.















